Brain Tumor Surgery
Brain Tumor Surgery
What You'll Learn
- Maximal safe resection: extent of resection correlates with survival for both low-grade and high-grade gliomas — gross total resection (GTR) is the goal when safely achievable
- Stereotactic biopsy: preferred for deep-seated, eloquent, multifocal lesions, or when lymphoma is suspected (need tissue, not resection)
- Awake craniotomy: indicated for tumors near eloquent cortex (motor strip, Broca, Wernicke) — uses direct cortical stimulation mapping
- Simpson grading (meningioma): degree of resection predicts recurrence — Grade I (complete resection + dura + bone) has lowest recurrence
- Stereotactic radiosurgery (SRS): single-fraction high-dose radiation; recommended for 1–4 brain metastases with reasonable performance status, conditionally for 5–10 in selected patients (ASTRO 2022; individual lesion typically <3 cm); also for vestibular schwannoma, residual meningioma, and AVMs
- 5-ALA fluorescence: oral administration before HGG surgery → tumor fluoresces pink under blue light → improves GTR rates
- Seizure prophylaxis: NOT routinely recommended for all brain tumors (AAN guideline) — consider for cortical tumors with seizure history
HighYield Pearls
- Suspected CNS lymphoma: stereotactic biopsy — NOT resection; hold steroids pre-biopsy when possible (transient regression obscures histology)
- 5-ALA (Gleolan) oral preop: pink fluorescence under blue light during HGG resection → FDA-approved adjunct that improves GTR in malignant glioma
- Awake craniotomy with cortical mapping: standard of care for tumors in/near eloquent cortex (motor, Broca, Wernicke) — maximizes resection while preserving function
- Resected limited brain metastases: postoperative cavity SRS is generally preferred over WBRT to preserve cognition (ASTRO 2022); WBRT is reserved for selected extensive disease or when SRS is not appropriate — use hippocampal avoidance + memantine when WBRT is given
- GBM postop pathway: Stupp protocol — concurrent TMZ + RT (6 wk) → adjuvant TMZ (6 cycles) ± TTFields (Optune); start RT within 3–6 wk of resection
- Transsphenoidal pituitary surgery: monitor for DI, SIADH, hypopituitarism, and CSF rhinorrhea (meningitis risk) — check sodium serially postop
- Posterior fossa surgery in children: watch for cerebellar mutism syndrome 24–72 h postop (medulloblastoma, ependymoma) — mutism + ataxia + emotional lability, recovers over months
- Seizure prophylaxis (ASCO/AAN): NOT routine for non-seizure brain tumor patients; if used perioperatively, taper within ~7 days — avoid enzyme-inducing AEDs with chemo
- Postop MRI within 24–72 h: required to define extent of resection; delayed imaging overestimates residual tumor due to postop enhancement
- New enhancement within 3 months of chemoRT: consider pseudoprogression vs true progression — use MR perfusion, FDG/MET PET, or biopsy before changing therapy
🔍 Quick ReferenceIndication / approach · Adjuncts · Complications
Indication / approach
- Tumor near motor strip / Broca / Wernicke → awake craniotomy with direct cortical stimulation mapping
- Deep-seated, eloquent, or multifocal lesion (lymphoma suspected) → stereotactic needle biopsy (frame-based or frameless)
- Resected limited brain metastases (good performance status, controlled systemic disease) → postoperative cavity SRS preferred over WBRT (ASTRO 2022)
- Pituitary macroadenoma with chiasmal compression → endoscopic transsphenoidal resection (preserves normal pituitary)
- Newly diagnosed GBM, good performance status → maximal safe resection → Stupp (RT + concurrent/adjuvant TMZ) ± TTFields
- Low-grade glioma in young patient near eloquent cortex → supramarginal resection beyond FLAIR with intraoperative mapping
Intraoperative adjuncts
- 5-ALA (Gleolan), oral preop, pink fluorescence under blue light → HGG resection — improves GTR
- Intraoperative MRI (iMRI) → real-time update for brain shift, confirms extent of resection
- Neuronavigation (frame-based / frameless stereotaxy) → image-guided trajectory for biopsy or resection
- SSEP / MEP / EMG neuromonitoring → posterior fossa, brainstem, spinal cord, cranial nerve preservation
- Direct cortical & subcortical stimulation (arcuate fasciculus, IFOF, CST) → language and motor mapping during awake craniotomy
- Carmustine (Gliadel) wafers → placed in resection cavity for HGG local chemotherapy
Complications / postop
- Mute, ataxic child 24–72 h after posterior fossa resection → cerebellar mutism (posterior fossa syndrome) — medulloblastoma/ependymoma
- Polyuria + hypernatremia + dilute urine after transsphenoidal surgery → central diabetes insipidus (DI)
- Clear rhinorrhea + headache + fever after transsphenoidal surgery → CSF leak → meningitis risk
- New enhancement within 3 months of chemoRT for GBM → pseudoprogression (vs true progression — use MR perfusion / FDG or MET PET)
- Late enhancing necrotic lesion at prior RT field → radiation necrosis → bevacizumab, steroids, LITT
- Lower cranial nerve palsy or apnea after posterior fossa surgery → brainstem injury
Resection vs. Biopsy Decision
Surgical Goals in Neuro-Oncology
- Maximal safe resection: primary surgical goal for most gliomas — remove as much tumor as possible without causing new neurological deficits
- Cytoreduction benefits: tissue diagnosis, molecular profiling (IDH, 1p/19q, MGMT), relief of mass effect, reduced tumor burden for adjuvant therapy
- Extent of resection (EOR) is an independent prognostic factor in both low-grade gliomas (LGG) and high-grade gliomas (HGG)
Resection vs. Biopsy: Decision Factors
| Factor | Favors Resection | Favors Biopsy |
|---|---|---|
| Location | Non-eloquent cortex, accessible | Deep-seated (thalamus, basal ganglia, brainstem), eloquent cortex without mapping feasibility |
| Number of lesions | Single, well-circumscribed | Multifocal or diffusely infiltrating |
| Suspected pathology | Glioma, meningioma, metastasis | Lymphoma suspected (steroid-responsive; avoid resection — treat with chemo/radiation) |
| Mass effect | Significant midline shift, herniation risk | Minimal mass effect |
| Patient status | Good KPS (≥70), tolerable surgical risk | Poor KPS, significant comorbidities |
| Goal | Cytoreduction + tissue diagnosis | Tissue diagnosis only |
Types of Biopsy
- Stereotactic needle biopsy: frame-based or frameless neuronavigation; targets deep or eloquent lesions; diagnostic yield ~90–95%; complication rate ~2–5% (hemorrhage)
- Open biopsy: small craniotomy for tissue sampling; used when stereotactic approach is not feasible (e.g., posterior fossa, highly vascular lesion)
- Diagnostic pitfall: sampling error — biopsy may not capture the highest-grade region of a heterogeneous tumor
Extent of Resection and Outcomes
| EOR | Definition | Impact |
|---|---|---|
| Gross total resection (GTR) | No residual enhancing (HGG) or FLAIR (LGG) tumor on postop MRI | Longest OS; associated with improved PFS in both LGG and HGG |
| Subtotal resection (STR) | Residual tumor visible on postop MRI | Intermediate survival; adjuvant RT/chemo more critical |
| Biopsy only | No meaningful cytoreduction | Shortest OS; reserved when resection is unsafe |
- Postop MRI: obtain within 24–72 hours to assess EOR and distinguish residual tumor from surgical changes
- Supramarginal resection: in LGG, resection beyond the FLAIR abnormality (into normal-appearing brain) may improve survival — requires intraoperative mapping
Board Pearls
- CNS lymphoma: do NOT resect — stereotactic biopsy for diagnosis; avoid steroids before biopsy if possible (can cause transient regression, complicating histology)
- EOR is a stronger prognostic factor in IDH-mutant gliomas than IDH-wildtype — maximal resection is especially important
- Postop MRI should be obtained within 24–72 hours — delayed imaging overestimates residual tumor due to postoperative enhancement
Awake Craniotomy
Indications
- Tumors in or adjacent to eloquent cortex: primary motor cortex, supplementary motor area (SMA), Broca area (dominant inferior frontal gyrus), Wernicke area (dominant posterior superior temporal gyrus)
- Goal: maximize resection while preserving neurological function through real-time cortical and subcortical mapping
- Most commonly used for low-grade gliomas in young patients where preserving function is paramount
Technique: Asleep-Awake-Asleep
- Phase 1 (Asleep): general anesthesia or deep sedation for craniotomy opening, dural opening, exposure
- Phase 2 (Awake): patient awakened for cortical mapping — direct electrical stimulation (DES) of cortex and subcortical white matter while patient performs tasks (naming, counting, motor movements)
- Phase 3 (Asleep): resedation for hemostasis, closure
Cortical Mapping
- Motor mapping: low-frequency stimulation of precentral gyrus → observe contralateral muscle contractions (EMG monitoring)
- Language mapping: stimulation during object naming, counting, reading → speech arrest or paraphasic errors indicate eloquent site
- Positive site: stimulation produces a response (motor movement, speech arrest) → cortex is functional → must be preserved
- Safety margin: resection should maintain ≥1 cm from positive motor/language sites when possible
- Subcortical mapping: identifies white matter tracts (arcuate fasciculus, corticospinal tract, IFOF) during deep resection
Patient Selection
- Cooperative, able to follow commands and perform language/motor tasks for 45–90 minutes
- No severe anxiety, claustrophobia, or cognitive impairment that would prevent task performance
- Contraindications: severe dysphasia (cannot perform language tasks), morbid obesity (airway concern), uncontrollable cough
Clinical Pearl
SMA syndrome (contralateral akinesia and mutism) is common after resection of tumors involving the supplementary motor area — it is typically transient, resolving over days to weeks. This is NOT a reason to avoid resection, but patients should be counseled preoperatively.
Board Pearls
- Awake craniotomy allows real-time functional mapping — the gold standard for preserving eloquent cortex during tumor resection
- Language mapping requires the patient to be awake and performing tasks — motor mapping can be done under general anesthesia (but awake is preferred for both)
- Afterdischarge: stimulation-induced seizure during mapping — managed with cold saline irrigation to cortex; does not necessarily abort the procedure
Continue reading — sign in
The full note has more clinical pearls, tables, and board-focused tips. Free account, no fee.